Trial Profile
Pharmacotherapy of Generalized Anxiety Disorder With Seroquel: Normalization of Brain Stress and Reward Function.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 May 2017
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Acronyms GAD
- 01 Feb 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Feb 2010 New trial record